Epstein-Barr virus (EBV) nuclear antigen (EBNA) was purified from the Burkitt lymphoma line Raji and its EBV DNA-binding properties were characterized. EBNA binding protected fragments of about 30 bp of B95-8 cell-derived EBV DNA from an excess of DNase I. Human anti-EBNA antibodies prevented DNA binding. Purified extracts from EBNA-negative cells did not protect EBV DNA against DNase I digestion. Mapping of the EBV DNA fragments protected from endonuclease (EcoRI, HindIII, SalI) digestion revealed many binding sites. Similar results were obtained following mixing of crude cell extracts and HindIII-digested fragments of EBV DNA and subsequent immunoprecipitation of the EBNA-DNA complex. In experiments involving the analysis of EBV DNA, fragments were protected from DNase I digestion by purified EBNA.
The Epstein-Barr virus (EBV) nuclear antigen (EBNA) has been purified and analysed biochemically. EBNA clearly binds to heterologous DNA such as calf thymus DNA, but it is not known whether the antigen binds equally well to all DNA sequences (Luka et al., 1978) . Immunofluorescence studies have shown that EBNA is associated with metaphase chromosomes (Ohno et al., 1977) . It is possible to convert EBNA-negative nuclei (Ramos) in vitro to EBNA-positive nuclei by addition of the solubilized nuclear antigen from Raji cells (Hirsch et al., 1978) . EBNA shows higher binding affinity to double-stranded than to single-stranded DNA . The biologically active form of EBNA has a molecular weight of 170 000 to 200000 (Luka et al., 1978) , but a variety of polypeptides between 39K and 81K have been shown to possess EBNA activity as visualized on Western blots (Strnad et al., 1981) . According to recent evidence EBNA is encoded by the BamHI fragment K of the EBV DNA (Summers et al., 1982) , and Hennessy et al. (1983) have presented data that EBNA has a core of simple amino acid composition.
The biological functions of EBNA may stem from its DNA-binding properties. Conceivably, it may restrict the virus from entering the lytic cycle and/or it may be responsible for the transformation (immortalization) of the target cells. Further biochemical and functional characterization of EBNA is very important for the understanding of the mechanisms of transformation, viral DNA replication and selective gene expression. Towards this end, we have studied the interaction of purified EBNA with EBV DNA in v#ro.
EBNA was purified from Raji cells by dsDNA-cellulose chromatography followed by hydroxyapatite chromatography and chromatofocusing according to the method of Luka et al (1983) . To prevent proteolytic breakdown, 2 mM-phenylmethylsulphonyl fluoride (PMSF), 1 mM-tosylphenylalanine chloromethyl ketone and 10 gg/ml pepstatin A were included in all buffers. Analysis of the purified EBNA by SDS gel electrophoresis showed a major 65K and a minor 70K EBNA component, essentially without further contaminating bands. Chromatofocusing suggested that the EBNA polypeptides were acidic proteins, with a pI of about 5. The higher and the lower molecular weight components were structurally related according to the (Rigby et al., 1977) to asp. act. of 10 s c.p.m.Atg DNA. 50 ng DNA was used for each test.
results of peptide mapping and comparative amino acid analyses. DNA-binding proteins were prepared from the EBV genome-negative B JAB cells as described by Luka et al. (1980) . EBV was purified from B95-8 cell supernatants according to the method of Bornkamm et al. (1980) . The purified viral DNA was dissolved in 20 m~-Tris-HCl pH 7.5, 0.1 mM-EDTA in 1 ~tg DNA/10~tl buffer concentration and stored at -20 °C. Lambda DNA was obtained from Boehringer Mannheim.
All binding and protection reactions were at 20 °C. Between 0.05 and 0.1 ktg DNA was diluted into 100 ~tl buffer containing 20 mM-Tris-HC1 pH 7.5, 150 mM-KCI, 0.1 mM-EDTA, 1 mM-2-mercaptoethanol (2-ME), 10~ glycerol, 200 ~tg/100 ~tl bovine serum albumin and 2 ~tg/100 p.1 calf thymus DNA. The excess of calf thymus DNA was always present as a competitive DNA to reduce possible non-specific binding of EBNA to EBV DNA. After addition of purified EBNA, the binding reaction was allowed to proceed for 10 min. Digestion was then initiated by addition of MgC12 to 10 mM and of 5 ~tg DNase I, and the mixture was incubated for 6 min at 20 °C. The DNA bound to protein was collected on 13 mm diam. 0.45 gm nitrocellulose filters and washed thoroughly with 20mM-Tris-HC1 pH7.5 buffer containing 0.1 mM-EDTA, 1 mM-2-ME, 150 mM-KC1 and 10% glycerol. The filters were transferred to 1.5 ml Eppendorf tubes in 100 ~tl elution buffer (20 mM-Tris-HC1 pH 7.5, 0.1% SDS, 0.1 mM-EDTA) and incubated at 44 °C for 30 min. When the protected fragments were analysed by gel electrophoresis, the elution buffer was 10 mM-Tris-borate pH 8.3, 0.05 mM-MgC12, 0.l % SDS, 10% glycerol, 0.025% bromophenol blue, 0.25 % xylene cyanol FF.
First we tested the ability of EBNA to protect DNA from nuclease digestion in the presence or absence of specific anti-EBNA serum. Fifty ~tl human serum (anti-EBNA-positive or -negative serum) was mixed with Protein A-Sepharose diluted 50% in 20 mM-Tris-HC1 pH 7-5, 150 mM-KC1, 1 mM-EDTA. After 12h at 4°C the Protein A-Sepharose-IgG complexes were centrifuged (500 g). The pellets were washed five times with the same buffer, EBNA (250 ng in the same buffer containing 10% glycerol) was mixed with them and left for 1 h at 4 °C. After centrifugation the supernatant was used for further absorption with fresh Protein A-SepharoseIgG complexes. Usually this was repeated twice, and the remaining supernatant was used for DNA binding.
The binding of EBV DNA to the membrane filter was dependent on EBNA, since EBNA antibody-containing human serum inhibited the binding reaction (Table 1) ; EBV-negative serum had no effect. Table 1 also shows that mock EBNA (from B JAB cells) failed to induce a binding reaction.
Mapping of the binding sites of EBNA to EBV DNA showed that EBNA-protected DNA sequences hybridized to practically all restriction fragments, particularly to the larger ones (Fig. 1,  lanes 2) . No hybridization was seen with mock EBNA-exposed EBV DNA fragments or with EBNA-protected lambda DNA fragments. When the molarity of KC1 was increased the hybridization pattern remained the same (data not shown). Therefore, 150 mM-KC1 was used throughout. The protected fragments separated by acrylamide gel electrophoresis were also used for hybridization to blots containing EcoRI, HindIII or SalI endonuclease-digested fragments of EBV D N A . For this purpose the gel slices containing protected fragments were excised and D N A was eluted as described by Maxam & Gilbert (1977) . Fig. 1 (lanes 3) shows the Specific DNA binding by EBNA was also examined by immunoprecipitation of EBNA bound to EBV DNA HindlII restriction fragments at 4 °C. Frozen Raji or B JAB cell pellets were suspended 1:4 in buffer (20 mM-Tris-HC1 pH 7.5, 150 mM-KC1, 1 mM-EDTA, 1 mM-2-ME, 1 mM-PMSF). The cells were then centrifuged at 38 000 g for 60 min at 4 °C. The supernatant was removed and used for further experiments. To 300 ~tl cell extract 50 ng 3' end-labelled HindlII fragments of EBV DNA, 50 ng calf thymus DNA and 1 ~tg bovine serum albumin were added and the reaction was kept at 4 °C for 4 h. Twenty ~tl of human convalescent anti-EBNA serum (or negative serum) was added for an additional 1 h followed by 50 ~tl 50~ Protein ASepharose diluted in the same buffer. After 30 min incubation at 4 °C the immune complexes were pelleted by centrifugation (500 g), the pellets were washed five times in extraction buffer, DNA fragments were dissociated from the immune complex by incubation in 100 ~tl 20 mMTris-HC1 pH 7.5, 10 mM-2-ME and 1 ~ SDS for 30 rain at 20 °C as described by Scheller et al. (1982) , 300 ~tl of water was added and the mixture was centrifuged. The supernatant was removed, phenol-extracted and used for hybridization. The results were similar to those of the previous experiments, showing many binding sites on EBV DNA (Fig. 3) . When the anti-EBNA serum was replaced with the serum of an EBV-negative human donor, there was no hybridization (Fig. 3, lanes 3) , nor was there any hybridization when B JAB cell extracts were used instead of the Raji cell extracts (data not shown).
Our experiments provided further results on the DNA-binding properties of EBNA. In our experimental system using highly purified EBNA and EBV DNA a strong protein-DNA interaction was demonstrated, with many binding sites on linear virion DNA. The immunoprecipitation experiment with crude EBNA preparation further confirmed that the binding of EBV DNA to the filters was mediated by EBNA, through many binding sites. It is still possible that EBV DNA has specific binding sites for EBNA, but that this could not be detected under our experimental conditions. Further experiments are required to study the EBNA-EBV DNA interaction using different forms of viral DNA under different conditions.
We can conclude from our data that EBNA is probably tightly bound to EBV DNA in vivo and may protect the large episomal viral genome copies from breakdown.
